Presented for research literature review only Nasca C et al
The Estonian Biobank Research Team responsible for data collection, genotyping, QC and imputation: A
6 Conclusion and future perspective Current therapies for osteoarthritis (OA) largely aim to relieve pain and slow cartilage loss, yet precise multitarget intervention within the complex OA microenvironment remains inadequate
Differences in experimental design are also likely to contribute to differences in results

ACS: acute coronary syndrome AF: atrial fibrillation ALC: acetyl- L -carnitine ASCVD: atherosclerotic cardiovascular disease ATP: adenosine triphosphate BCAAs: branched-chain amino acids CAD: coronary artery disease CKD: chronic kidney disease CPT: carnitine palmitoyltransferase DRIs: Dietary Reference Intakes ER: endoplasmic reticulum F/B: Firmicutes-to-Bacteroidetes FMOs: flavin monooxygenases FNB: Food and Nutrition Board GPLC: glycine propionyl- L -carnitine GSH: glutathione HF: heart failure IL-6: interleukin 6 LC: L -carnitine LC-MS/MS: liquid chromatography-tandem mass spectrometry MACE: major adverse cardiac events MAFLD: metabolic-dysfunction-associated fatty liver disease MDA: malondialdehyde MI: myocardial infarction NAFLD: non-alcoholic fatty liver disease NF-B: nuclear factor kappa-light-chain-enhancer of activated B cells PH: pulmonary hypertension SCD: sudden cardiac death SCFAs: short-chain fatty acids SYNTAX: Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery T2D: type 2 diabetes T2DM: type 2 diabetes mellitus TC: total carnitine TCA cycle: tricarboxylic acid cycle TMA: trimethylamine TMAO: trimethylamine- N -oxide HSW: Conceptualization, Writingoriginal draft, Writingreview & editing, Supervision, Validation

Sterile water lacks this preservative and should only be used for single-dose reconstitution